---
title: "=====\n\nSYNERGY: Empagliflozin has received a drug registration certificate in South Korea\n\n====="
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/228833242.md"
description: "According to the Zhitong Finance APP, SYNERGY announced that the company recently received the drug registration certificate for Empagliflozin issued by the Ministry of Food and Drug Safety (MFDS) of South Korea, which is suitable for the treatment of type 2 diabetes"
datetime: "2025-02-19T09:53:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/228833242.md)
  - [en](https://longbridge.com/en/news/228833242.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/228833242.md)
generator: "portal-rs"
---

# =====

SYNERGY: Empagliflozin has received a drug registration certificate in South Korea

=====

According to the Zhitong Finance APP, SYNERGY (300636.SZ) announced that the company recently received the drug registration certificate for Empagliflozin issued by the Ministry of Food and Drug Safety (MFDS) of South Korea, which is suitable for the treatment of type 2 diabetes

### Related Stocks

- [300636.CN](https://longbridge.com/en/quote/300636.CN.md)

## Related News & Research

- [Livzon Pharma buys 3.5% Xinbeijiang Pharma stake for RMB 106.7 million](https://longbridge.com/en/news/296601614.md)
- [Promise Analyzes Telehealth Licensing Rules as Compact Hits Record 3,633 Licenses in a Month](https://longbridge.com/en/news/296635882.md)
- [US health agencies report 55 cases of E. coli and salmonella infections tied to alfalfa sprouts](https://longbridge.com/en/news/296645342.md)
- [Desert Control issued shares rise to 407,935,164 after capital increase registration](https://longbridge.com/en/news/296688306.md)
- [FOCUS-Green giant: How Taylor Farms became a top salad supplier before US diarrhea outbreak](https://longbridge.com/en/news/296469939.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**